Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
The University of Utah Health in Salt Lake City invites applications for the Director of Cellular Therapy. This leadership role will provide strategic direction for expanding cellular therapy programs across Huntsman Cancer Institute and the university system.
The successful candidate will lead a network spanning clinical, translational, and laboratory teams to advance therapies for hematologic malignancies and other diseases, with protected administrative time and resources to support program
Position/Rank Director of Cellular Therapy
Department 00847 - Hematology
City Salt Lake City, UT
Track Track Dependent on Qualifications
New Position to Begin Upon Hire
We are seeking an MD or MD/PhD with expertise in cellular therapy to serve as the Director of Cellular Therapy. This position will provide strategic leadership for the expansion of cellular therapy programs across Huntsman Cancer Institute and the University of Utah Health system.
The successful candidate will play a central role in building and leading a comprehensive cellular therapy network, advancing innovative therapies for patients with hematologic malignancies and other diseases. The Director will work closely with clinical, translational, and laboratory leaders to integrate discovery, manufacturing, and clinical application of cellular therapies.
This leadership position includes protected administrative time, the possibility of an endowed chair, and dedicated programmatic resources to support program development, research initiatives, and network expansion.
The Director will hold a faculty appointment in the Division of Hematology and Hematologic Malignancies within the Department of Internal Medicine and will become an investigator at Huntsman Cancer Institute, an NCI -Designated Comprehensive Cancer Center.
The Cell Therapy and Regenerative Medicine (CTRM) Program at the University of Utah provides state-of-the-art infrastructure to support the development and manufacturing of cellular therapy products.
The program has the capability to develop and produce clinical-grade cellular therapies in-house, enabling investigators and clinicians to translate innovative cellular therapies from bench to bedside.